The AP and LP both contribute to diseases as AMD and ischemia–reperfusion injuries, were MAP-1:CD551-4, MAP-1:CD351-3, and sMAP-FH could potentially aid in the treatment of such pathologies. This evidence concerns the gene MASP2 and age-related macular degeneration.